Clinical practice guideline for clozapine use in patients with COVID‐19.

Autor:	Ansari, Saba, Kelbrick, Marlene, Paduret, Gabriela, Diaz, Natasha, Menzel, Rose, Rogers, Rowena, Wareham, Claire, Griffiths, Chris, Jugon, Sue, Tidy, Katy, Johnson, Sara, Mann, Nick, Tanner, James, Millward, Tim, Latif, Shahid
Předmět:	DRUG therapy for psychoses DRUG therapy for schizophrenia COVID-19 MEDICAL protocols RISK assessment CLOZAPINE DRUG prescribing PHYSICIAN practice patterns ANTIPSYCHOTIC agents MENTAL health services
Zdroj:	Progress in Neurology & Psychiatry; Jan2023, Vol. 27 Issue 1, p31-36, 6p
Abstrakt:	National and local guidelines focus mainly on clozapine monitoring frequency, and actions based on full blood count results. Prescribing clozapine in the context of COVID‐19‐positive patients brings a complexity of challenge beyond this. In this article the authors put forward an example of a practical clinical guideline in this regard. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu